This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Impact of Asthma Treatments on Daily Activities

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2006 by Ovation Research Group.
Recruitment status was:  Recruiting
Genentech, Inc.
Information provided by:
Ovation Research Group Identifier:
First received: July 5, 2006
Last updated: NA
Last verified: July 2006
History: No changes posted
The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Asthma Allergies

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)

Further study details as provided by Ovation Research Group:

Estimated Enrollment: 1500
Study Start Date: June 2006

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Have asthma and allergies
  • Currently taking Xolair® or Advair®
  • Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
  • Between 18 and 55 years of age
  • A non-smoker for at least 6 months
  • Have internet access
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00350376

Contact: Nita Ngo, MPH 888.631.9167

United States, California
Ovation Research Group Recruiting
San Francisco, California, United States, 94105
Principal Investigator: Susan D Mathias, MPH         
Sponsors and Collaborators
Ovation Research Group
Genentech, Inc.
Principal Investigator: Susan D Mathias, MPH Ovation Research Group
  More Information Identifier: NCT00350376     History of Changes
Other Study ID Numbers: 1467
Study First Received: July 5, 2006
Last Updated: July 5, 2006

Keywords provided by Ovation Research Group:

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on September 19, 2017